Issuance of stock acquisition rights to directors and employees
First written in FY2017-Q2. 24 of 25 entries say "Advanced", first in FY2017-Q3. Latest entry: FY2026-H1.
- FY2026-H1AdvancedAnnual report
「1 April 2025–30 September 2025 (Note) 3,400 33,603,924 1,803 7,881,920 1,803 6,993,911 (Note) Increase due to the exercise of stock acquisition rights.」
During the interim consolidated accounting period, the total number of issued shares increased by 3,400 through the exercise of stock acquisition rights, while stated capital and the capital reserve each increased by ¥1.803 million. - FY2025-H1AdvancedAnnual report
「1 April 2024–30 September 2024 (Note) 32,600 33,599,524 17,549 7,879,586 17,549 6,991,577 (Note) Increase due to the exercise of stock acquisition rights.」
During the interim consolidated accounting period, the total number of issued shares increased by 32,600 through the exercise of stock acquisition rights, while stated capital and the capital reserve each increased by ¥17.549 million. - FY2024-Q2AdvancedAnnual report
「1 July 2023–30 September 2023 (Note) 2,500 33,550,424 1,362 7,853,189 1,362 6,965,180 (Note) Increase due to the exercise of stock acquisition rights.」
During the second quarter, the total number of issued shares increased by 2,500 through the exercise of stock acquisition rights, while stated capital and the capital reserve each increased by ¥1.362 million. - FY2024-Q1AdvancedAnnual report
「1 April 2023–30 June 2023 (Note) 6,800 33,547,924 3,952 7,851,826 3,952 6,963,817 (Note) Increase due to the exercise of stock acquisition rights.」
During the first quarter, the total number of issued shares increased by 6,800 through the exercise of stock acquisition rights, while stated capital and the capital reserve each increased by ¥3.952 million. - FY2023-Q3AdvancedAnnual report
「1 October 2022–31 December 2022 (Note) 1 76,400 33,818,924 43,888 7,761,676 43,888 6,873,668 (Note) 1. Increase due to the exercise of stock acquisition rights. / 2. From 1 January 2023 to 31 January 2023, the total number of issued shares increased by 3,500 through the exercise of stock acquisition rights, while stated capital and the capital reserve each increased by ¥2.226 million.」
During the third quarter, the total number of issued shares increased by 76,400 through the exercise of stock acquisition rights; an additional increase of 3,500 shares in January 2023, before the filing date, is also disclosed. - FY2023-Q2AdvancedAnnual report
「1 July 2022–30 September 2022 (Note) 93,600 33,742,524 53,762 7,717,787 53,762 6,829,779 (Note) Increase due to the exercise of stock acquisition rights.」
During the second quarter, the total number of issued shares increased by 93,600 through the exercise of stock acquisition rights, while stated capital and the capital reserve each increased by ¥53.762 million. - FY2022-Q1AdvancedAnnual report
「1 April 2021–30 June 2021 (Note) 19,800 34,490,324 6,276 7,629,915 6,276 6,741,906 (Note) Increase due to the exercise of stock acquisition rights.」
During the first quarter, the total number of shares issued and outstanding increased by 19,800 shares through the exercise of stock acquisition rights, while capital stock and the capital reserve each increased by ¥6.276 million. - FY2021AdvancedAnnual report
「1 April 2020–30 November 2020 (Note) 1 24,900 / 1 December 2020–31 March 2021 (Note) 1 64,100 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the fiscal year, the number of shares increased by a total of 89,000 through the exercise of stock acquisition rights for directors and employees, and capital stock and the capital reserve also increased. - FY2021-Q3AdvancedAnnual report
「1 October 2020–30 November 2020 (Note) 1 4,000 / 1 December 2020–31 December 2020 (Note) 1 22,000 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the third quarter, the total number of shares issued and outstanding increased by 26,000 shares through the exercise of stock acquisition rights, while capital stock and the capital reserve each increased by ¥8.242 million. An additional exercise of 4,000 shares through the filing date is also disclosed. - FY2021-Q2AdvancedAnnual report
「Date of resolution 25 June 2020 Categories and number of eligible holders (people) Company directors 4 Company employees 147 Directors and employees of subsidiaries 13 Number of stock acquisition rights (units) * 3,268 Class, terms and number of underlying shares (shares) * Common shares 326,800 Amount payable upon exercise of stock acquisition rights (¥) * 890 Exercise period of stock acquisition rights * 1 July 2022 to 30 June 2025」
On 17 August 2020, the Company issued 3,268 stock acquisition rights representing 326,800 underlying shares for directors, employees and subsidiary officers and employees. The exercise period is from 1 July 2022 to 30 June 2025. - FY2021-Q1AdvancedAnnual report
「1 April 2020–30 June 2020 (Note) 1 7,500 36,389,024 3,079 7,597,105 3,079 6,709,097 (Note) 1. Increase due to the exercise of stock acquisition rights. / 2. From 1 July 2020 to 31 July 2020, the total number of shares issued and outstanding increased by 100 shares, while capital stock and the capital reserve each increased by ¥31,000 through the exercise of stock acquisition rights.」
During the first quarter, the total number of shares issued and outstanding increased by 7,500 shares through the exercise of stock acquisition rights, and a further 100-share increase is disclosed through the filing date. - FY2020AdvancedAnnual report
「1 April 2019–31 March 2020 155,300 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the fiscal year, the number of shares increased by 155,300 through the exercise of stock acquisition rights, while capital stock increased by ¥52.333 million and the capital reserve by ¥52.402 million. Stock acquisition rights for directors and employees granted in 2019 remained outstanding. - FY2020-Q3AdvancedAnnual report
「1 October 2019–31 December 2019 (Note) 41,400 36,367,924 17,394 7,588,111 17,394 6,700,102 (Note) Increase due to the exercise of stock acquisition rights.」
During the third quarter, the total number of shares issued and outstanding increased by 41,400 shares through the exercise of stock acquisition rights, while capital stock and the capital reserve each increased by ¥17.394 million. - FY2020-Q2AdvancedAnnual report
「1 July 2019–30 September 2019 (Note) 1 72,500 36,326,524 17,687 7,570,716 17,659 6,682,708 (Note) 1. Increase due to the exercise of stock acquisition rights. / 2. From 1 October 2019 to 31 October 2019, the total number of shares issued and outstanding increased by 1,300 shares, while capital stock and the capital reserve each increased by ¥412,000 through the exercise of stock acquisition rights.」
During the second quarter, the number of shares increased by 72,500 through the exercise of stock acquisition rights, and the disclosure records a further 1,300-share increase in October before the filing date. - FY2020-Q1AdvancedAnnual report
「1 April 2019–30 June 2019 (Note) 1. Increase due to the exercise of stock acquisition rights. / 2. From 1 July 2019 to 31 July 2019, the total number of shares issued and outstanding increased by 29,900 shares, capital stock by ¥914,000 and the capital reserve by ¥887,000 through the exercise of stock acquisition rights.」
During the first quarter, the total number of shares issued and outstanding increased by 27,800 shares through the exercise of stock acquisition rights, while capital stock and the capital reserve each increased by ¥11.384 million. In addition, the disclosure records a 29,900-share increase in July. - FY2019AdvancedAnnual report
「1 April 2018–31 March 2019 202,100 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the fiscal year, the number of shares increased by 202,100 through the exercise of stock acquisition rights, while capital stock increased by ¥83.450 million and the capital reserve by ¥83.406 million. Stock acquisition rights for directors and employees granted in 2018 are also disclosed. - FY2019-Q3AdvancedAnnual report
「1 October 2018–31 December 2018 (Note) Increase due to the exercise of stock acquisition rights.」
During the third quarter, the total number of shares issued and outstanding increased by 1,000 shares through the exercise of stock acquisition rights, while capital stock and the capital reserve each increased by ¥317,000. - FY2019-Q2AdvancedAnnual report
「Date of resolution 28 June 2018 Categories and number of eligible holders (people) Company directors 5 Company employees 211 Directors and employees of subsidiaries 11 Number of stock acquisition rights (units) * 3,323 Class, terms and number of underlying shares (shares) * Common shares 332,300 Exercise period of stock acquisition rights * 1 July 2020 to 30 June 2023 * The terms as of the issuance of the stock acquisition right certificates (17 August 2018) are disclosed. / 1 July 2018–30 September 2018 51,000 (Note) 1. Increase due to the exercise of stock acquisition rights.」
On 17 August 2018, the Company issued 3,323 stock acquisition rights representing 332,300 underlying shares for directors and employees, and the number of shares increased by 51,000 through exercises during the second quarter. - FY2019-Q1AdvancedAnnual report
「1 April 2018–30 June 2018 113,400 36,137,524 53,075 7,511,317 53,034 6,623,243 (Note) 1. Increase due to the exercise of stock acquisition rights. / 2. From 1 July 2018 to 31 July 2018, the total number of shares issued and outstanding increased by 7,500 shares, capital stock by ¥2.839 million and the capital reserve by ¥2.838 million through the exercise of stock acquisition rights.」
During the first quarter, the total number of shares issued and outstanding increased by 113,400 shares through the exercise of stock acquisition rights, and capital stock and the capital reserve also increased. In addition, a 7,500-share increase in July is disclosed. - FY2018-Q3AdvancedAnnual report
「1 October 2017–31 December 2017 102,800 35,957,924 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the third quarter, the total number of shares issued and outstanding increased by 102,800 shares through the exercise of stock acquisition rights, while capital stock increased by ¥46.227 million and the capital reserve by ¥46.202 million. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the six-month accounting period are as follows. / Number of stock acquisition rights (units) 750 / Number of underlying shares (shares) 75,000 / Exercise period: 1 July 2019 to 30 June 2022 / 1 July 2017–30 September 2017 78,900 (Note) 1. Increase due to the exercise of stock acquisition rights.」
The Company issued 750 stock acquisition rights approved by the Board of Directors, representing 75,000 underlying shares, and the number of shares increased by 78,900 through the exercise of stock acquisition rights during the second quarter. The issue approved by the Annual General Meeting of Shareholders is also disclosed as 2,353 rights representing 235,300 shares. - FY2018-Q1AdvancedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
During the first quarter, the total number of shares issued and outstanding increased by 96,600 shares through the exercise of stock acquisition rights, while capital stock and the capital reserve each increased by ¥31.914 million. - FY2017AdvancedAnnual report
「The 68,500-share increase in the total number of issued common shares resulted from the issuance of new shares upon the exercise of stock acquisition rights.」
During the fiscal year, 68,500 shares were issued through the exercise of stock acquisition rights. In addition, stock acquisition rights for directors and employees granted in 2016 remained outstanding, and the disclosure also records a resolution on 28 June 2017 to issue new stock acquisition rights for directors and employees. - FY2017-Q3AdvancedAnnual report
「1 October 2016–31 December 2016 (Note) Increase due to the exercise of stock acquisition rights.」
While no new stock acquisition rights were issued during the third quarter, the total number of shares issued and outstanding increased by 8,100 shares through exercises, confirming exercises of the previous issue. - FY2017-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows.」
Reports the issuance of 730 stock acquisition rights covering 73,000 shares pursuant to a Board resolution and 2,340 rights covering 234,000 shares pursuant to an Annual General Meeting resolution. Both have an exercise price of ¥536 and an exercise period from 1 July 2018 to 30 June 2021, and are exercisable by directors, advisors and employees, among others.